Company news
Valirx Plc (LSE:VAL) news
Valirx Plc news releases on 6ix. Latest, Oct 3, 2013: Re: VAL201 - Filing of Phase IB Clinical Trial
Press releases — page 7
Re: VAL201 - Filing of Phase IB Clinical Trial
October 3, 2013
Consortium incl. ValiRx Awarded Eurostars Grant
August 15, 2013
Investor Presentation in Manchester
June 25, 2013
Re: VAL201 Update
June 13, 2013
ValiRx admitted as founder member of the SSE
June 6, 2013
New Patent Granted
April 25, 2013
Update on Developmental and Clinical Activity
April 2, 2013
Re Commercial Development Update
February 21, 2013
Appointment of Medical Monitoring Officer
January 23, 2013
Re: Update
November 22, 2012
Placing and Notice of General Meeting
November 1, 2012
re: UK Distribution Agreement
October 11, 2012
VAL201 Update re: Breast Cancer Study
September 6, 2012
Re: GeneICE and Biomarkers Development Update
August 2, 2012
Update re: Late Pre-clinical Study of VAL201
May 29, 2012
New US Patent Grant
May 15, 2012
Placing of GBP 900,000 and Director's Dealing
April 2, 2012
Re Agreement
March 29, 2012
Peer Review Findings Published re VAL201
March 8, 2012
Establishment of Scientific & Advisory Board
February 14, 2012
New Patent Grant for GeneICE & VAL101 Update
December 15, 2011
Re Volition - Allotment of Shares
December 9, 2011
Appointment of SELFCheck Distributor
November 24, 2011
New Patent Filing
November 3, 2011
Volition Update
October 7, 2011
Re BioPartnering Europe 2011 Conference
September 29, 2011
Re: Collaborative Agreement
September 13, 2011
Distribution Agreement
September 8, 2011
Acquisition of Finnish Non-Trading Company
August 18, 2011
AGM Statement
June 23, 2011
GeneICE Update
June 21, 2011
Volition - update
June 10, 2011
Publication of Report & Accounts and Notice of AGM
May 31, 2011
Website update
May 20, 2011
Agreements with Imperial College & Oxford Uni
April 14, 2011
Re Self-Test Health Report
April 4, 2011
SELFCheck Update
March 24, 2011
Result of EGM
March 7, 2011
Website Update
February 25, 2011
Publication of Circular and Notice of GM
February 18, 2011
Further re Sale of Belgian Su
January 31, 2011
Publication of Circular and N
January 11, 2011
Update - Eurostars Programme
December 2, 2010
Issue of equity and update
November 10, 2010
Completion of Disposal
October 11, 2010
Disposal
September 23, 2010
Licensing Deal with Cancer Re
August 12, 2010
HPV Test Starts Clinical Vali
July 15, 2010
Eurostars' GeneICE Programme
June 17, 2010
Issue of Equity - Replacement
April 21, 2010